OXYTROL OXYBUTYNIN TRANSDERMAL SYSTEM

Allergan Sales, Llc

Application Filed: 2003-02-07

Trademark Application Details

Mark For: OXYTROL OXYBUTYNIN TRANSDERMAL SYSTEM® trademark registration is intended to cover the category of medical transdermal patches for the delivery of anticholinergic agents. [all]

Status

2022-07-01 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76488369
Registration Number	2911459
Mark Literal Elements	OXYTROL OXYBUTYNIN TRANSDERMAL SYSTEM
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2004-11-01
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	STEPHANIE K. WADE
Attorney Docket Number	W1715.0785
Law Office Assigned	L50
Employee Name	PAPPAS, MATTHEW JAMES

Timeline

2002-04-22	Date of First Use
2002-04-22	Date of Use In Commerce
2003-02-07	Application Filed
2003-11-25	Published
2003-11-25	Published for Opposition
2004-11-01	Location: PUBLICATION AND ISSUE SECTION
2004-12-14	Trademark Registered
2011-07-15	Cancelled
2011-07-15	Status: Dead/Cancelled
2011-07-15	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	ALLERGAN SALES, LLC
Address	5 GIRALDA FARMS MADISON, NEW JERSEY UNITED STATES 07940
Legal Entity Type	Limited Liability Company
Legal Entity State	DELAWARE

Documents

Application		2003-02-07
Drawing		2003-02-07
XSearch Search Summary		2003-07-27
Offc Action Outgoing		2003-07-28
Examiners Amendment		2003-08-06
Amended Drawing		2003-09-22
Paper Correspondence Incoming		2003-09-22
Notice of Publication	APPLICATION/XML	2003-11-05
Notice of Allowance	APPLICATION/XML	2004-02-06
Paper Correspondence Incoming		2004-08-03
Paper Correspondence Incoming		2004-08-03
ITU Extension Approval	APPLICATION/XML	2004-08-24
Offc Action Outgoing		2004-08-26
Paper Correspondence Incoming		2004-09-09
Notation to File		2004-09-30
Notice of Acceptance of Statement of Use		2004-11-02
Registration Certificate		2004-12-14
Change of Address	APPLICATION/XML	2007-01-03

Design Search Codes

26.03.21	Ovals that are completely or partially shaded
26.11.21	Rectangles that are completely or partially shaded
260303	Incomplete ovals; Ovals, incomplete
260321	Ovals that are completely or partially shaded
261121	Rectangles that are completely or partially shaded

Attorney of Record

Stephanie K. Wade
Dickstein Shapiro LLP
1825 Eye Street, NW
Washington, DC 20006-5403

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: medical transdermal patches for the delivery of anticholinergic agents. FIRST USE: 20020422. FIRST USE IN COMMERCE: 20020422

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
D10000	"OXYBUTYNIN TRANSDERMAL SYSTEM"

Trademark Filing History

Description	Date	Proceeding Number
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2018-01-03
CANCELLED SEC. 8 (6-YR)	2011-07-15
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2007-01-03
REGISTERED-PRINCIPAL REGISTER	2004-12-14
LAW OFFICE REGISTRATION REVIEW COMPLETED	2004-10-06	78413
ASSIGNED TO LIE	2004-10-01	78413
AMENDMENT FROM APPLICANT ENTERED	2004-09-30	71373
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	2004-09-30
PAPER RECEIVED	2004-09-09
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-09-09	71373
NON-FINAL ACTION MAILED	2004-08-27
ASSIGNED TO EXAMINER	2004-08-24	74645
STATEMENT OF USE PROCESSING COMPLETE	2004-08-23
SOU EXTENSION 1 GRANTED	2004-08-23
USE AMENDMENT FILED	2004-08-03
SOU EXTENSION 1 FILED	2004-08-03
PAPER RECEIVED	2004-08-03
NOA MAILED - SOU REQUIRED FROM APPLICANT	2004-02-17
PUBLISHED FOR OPPOSITION	2003-11-25
NOTICE OF PUBLICATION	2003-11-05
PAPER RECEIVED	2003-09-22
APPROVED FOR PUB - PRINCIPAL REGISTER	2003-08-11
EXAMINERS AMENDMENT MAILED	2003-08-07
NON-FINAL ACTION MAILED	2003-07-29
ASSIGNED TO EXAMINER	2003-07-27	74645

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
OXYTROL OXYBUTYNIN TRANSDERMAL SYSTEM 76488369 2911459 Dead/Cancelled	ALLERGAN SALES, LLC 2003-02-07
OXYTROL OXYBUTYNIN TRANSDERMAL SYSTEM 76488368 not registered Dead/Abandoned	ALLERGAN SALES, LLC 2003-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.